Newer-Generation Antidepressants and Suicide Risk in Randomized Controlled Trials: A Re-Analysis of the FDA Database

Psychother Psychosom. 2019;88(4):247-248. doi: 10.1159/000501215. Epub 2019 Jun 24.

Authors

Michael P Hengartner¹, Martin Plöderl²

Affiliations

¹ Department of Applied Psychology, Zurich University of Applied Sciences, Zurich, Switzerland, michaelpascal.hengartner@zhaw.ch.
² Department for Crisis Intervention and Suicide Prevention and Department for Clinical Psychology, University Clinic for Psychiatry, Psychotherapy, and Psychosomatics, Paracelsus Medical University, Salzburg, Austria.

PMID: 31234169
DOI: 10.1159/000501215

No abstract available

Publication types

Letter

MeSH terms

Antidepressive Agents / adverse effects*
Humans
Placebos / adverse effects
Randomized Controlled Trials as Topic
Risk Factors
Suicide / statistics & numerical data*
Suicide, Attempted / statistics & numerical data*
United States
United States Food and Drug Administration

Substances

Antidepressive Agents
Placebos